Joëlle Guilhot
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 01, 2024
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia.François Guilhot, Rüdiger Hehlmann
|Jan 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.Francois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot
|Feb 12, 2020
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.Tom Hähnel, Christoph Baldow, Joëlle Guilhot
Pageof 1
Frequent Collaborators
2 joint publications
Tom Hähnel
2 joint publications
Christoph Baldow
2 joint publications
Stephanie Dulucq
2 joint publications
Ingmar Glauche
1 joint publications
Alain Delmer
1 joint publications
Emmanuel Gyan
1 joint publications
Bertrand Joly
1 joint publications
Eric Deconinck
1 joint publications
Jean-Claude Chomel
1 joint publications
Ludovic Lhermitte
